Drug Pipeline

Maralixibat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
2
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07290257 Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in… Alagille Syndrome Recruiting
Phase 3
NCT06553768 Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease… Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) Active, Not Recruiting
Phase 2/3
NCT06413368 Maralixibat in Patients With Cystic Fibrosis and Constipation Constipation Chronic Idiopathic Recruiting
Phase 2
NCT07389031 Maralixibat for Intrahepatic Cholestasis of Pregnancy Intrahepatic Cholestasis of Pregnancy Not Yet Recruiting
Not specified
NCT07293897 A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS)… Alagille Syndrome (ALGS) Recruiting
Sponsors Running Maralixibat Trials
Mirum Pharmaceuticals, Inc. (2) Children's Hospital Los Angeles (1) Takeda (1) Imperial College London (1)
Disease Areas
Cystic Fibrosis (1)
Get alerts when Maralixibat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free